A case of recalcitrant neovascular wet age-related macular degeneration treated with Intravitreal Brolucizumab

被引：0
|
作者：
Panigrahi, Pradeep Kumar [1 ,2 ]
机构：
[1] SOA Deemed Univ, Dept Ophthalmol, Inst Med Sci, 8 Kalinga Nagar, Bhubaneswar 751003, India
[2] SOA Deemed Univ, SUM Hosp, 8 Kalinga Nagar, Bhubaneswar 751003, India
来源：
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY | 2021年 / 35卷
关键词：
Brolucizumab; Age related macular degeneration; Intravitreal injection; Optical coherence tomography; MANAGEMENT;
D O I：
10.1016/j.pdpdt.2021.102450
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A 72-year-old male presented with loss of vision in left eye of 1 year duration. Patient had been diagnosed with wet neovascular age related macular degeneration in left eye and had received multiple injections of anti vascular endothelial growth factor agents in past. Clinical and imaging studies showed persistent subretinal fluid. The patient was shifted to intravitreal Brolucizumab. There was complete resolution of subretinal fluid with improvement of vision 1 month following injection. Improvement of vison was maintained 3 months following injection with macula remaining dry.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
    Maggio, Emilia
    Alfano, Alessandro
    Mete, Maurizio
    Pertile, Grazia
    CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (03): : 736 - 743
  • [2] Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
    Avaylon, Jaycob
    Lee, Sol
    Gallemore, Ron P.
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2020, 13 : 145 - 152
  • [3] Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept
    Hatz, Katja B.
    Cedro, Luca
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [4] Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration
    Book, Marius
    Ziegler, M.
    Rothaus, K.
    Faatz, H.
    Gutfleisch, M.
    Spital, G.
    Lommatzsch, A.
    Pauleikhoff, D.
    OPHTHALMOLOGE, 2022, 119 (03): : 258 - 264
  • [5] Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration
    Book, Marius
    Ziegler, M.
    Rothaus, K.
    Faatz, H.
    Gutfleisch, M.
    Spital, G.
    Lommatzsch, A.
    Pauleikhoff, D.
    OPHTHALMOLOGIE, 2022, 119 (03): : 258 - 264
  • [6] Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Ohr, Matthew
    Kaiser, Peter K.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (04) : 585 - 591
  • [7] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Ki Woong Bae
    Dong Ik Kim
    Daniel Duck-Jin Hwang
    Scientific Reports, 12
  • [8] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Bae, Ki Woong
    Kim, Dong Ik
    Hwang, Daniel Duck-Jin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [9] Clinical Outcomes of Intravitreal Brolucizumab Injection for Refractory Neovascular Age-related Macular Degeneration
    Lee, Jun Young
    Park, No Hae
    Kwon, Han Jo
    Park, Sung Who
    Byon, Ik Soo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (09): : 596 - 604
  • [10] Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration
    Lee, Sang Hyeok
    Lee, Mee Yon
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024,
12345